VitaNova Life Sciences (VNOV) Cash from Operations (QoQ) (2017 - 2026)
Analysis
VitaNova Life Sciences (VNOV) Cash from Operations (QoQ) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Accenture | 120.96 Bn | 111.91 Bn | 6.13 Bn |
| 2 | UL Solutions | 12.94 Bn | 12.53 Bn | 417.00 Mn |
| 3 | Gartner | 11.74 Bn | 10.25 Bn | 1.19 Bn |
| 4 | Booz Allen Hamilton Holding | 9.28 Bn | 8.74 Bn | 1.46 Bn |
| 5 | Tetra Tech | 9.14 Bn | 8.91 Bn | 243.21 Mn |
| 6 | Genpact | 5.74 Bn | 5.22 Bn | 490.34 Mn |
| 7 | Grand Canyon Education | 3.97 Bn | 3.69 Bn | 204.08 Mn |
| 8 | Fti Consulting | 3.91 Bn | 3.74 Bn | 316.27 Mn |
| 9 | Korn Ferry | 3.90 Bn | 3.09 Bn | 681.29 Mn |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.90 Mn | 30,521.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 573.92% |
| Jan 31, 2026 | -142.50% |
| Oct 31, 2025 | -19.39% |
| Jul 31, 2025 | -44.94% |
| Apr 30, 2025 | 129.39% |
| Jan 31, 2025 | 2,284.45% |
| Oct 31, 2024 | 101.74% |
| Jul 31, 2024 | -163.62% |
| Apr 30, 2024 | -26.99% |
| Jan 31, 2024 | -1,784.08% |
| Oct 31, 2023 | 69.44% |
| Jul 31, 2023 | -1,044.29% |
| Apr 30, 2023 | 91.89% |
| Jan 31, 2023 | -631.04% |
| Oct 31, 2022 | -21.75% |
| Jul 31, 2022 | 149.02% |
| Apr 30, 2022 | -363.87% |
| Jan 31, 2022 | -73.25% |
| Oct 31, 2021 | 382.24% |
| Jan 31, 2021 | 61.68% |